$CABA 4 SEC Filings

Filed On	Filing
10 Jun 2026	Form 4: Tomasello Shawn, Director Granted 22,000 Stock Option (Right to Buy)
10 Jun 2026	Form 4: Simon Mark, Director Granted 22,000 Stock Option (Right to Buy)
10 Jun 2026	Form 4: Henriques Richard C Jr, Director Granted 22,000 Stock Option (Right to Buy)
10 Jun 2026	Form 4: Bollard Catherine, Director Granted 22,000 Stock Option (Right to Buy)
10 Jun 2026	Form 4: Brun Scott C., Director Granted 22,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Das Arun, Chief Business Officer Granted 175,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Gerard Michael, General Counsel Granted 175,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Binder Gwendolyn, President, Science & Tech. Granted 225,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Chang David J., Chief Medical Officer Granted 225,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Nichtberger Steven, Director Granted 674,000 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Marda Anup, Chief Financial Officer Granted 225,000 Stock Option (Right to Buy)
21 Jan 2026	Form 4: Chang David J., Chief Medical Officer Bought 8,800 shares ($19.9K)
21 Jan 2026	Form 4: Binder Gwendolyn, President, Science & Tech. Bought 11,312 shares ($24.8K)
21 Jan 2026	Form 4: Tomasello Shawn, Director Bought 22,725 shares ($50.3K)
21 Jan 2026	Form 4: Gavel Steve, Chief Commercial Officer Bought 22,170 shares ($50.2K)
21 Jan 2026	Form 4: Bollard Catherine, Director Bought 4,405 shares ($9.98K)
21 Jan 2026	Form 4: Nichtberger Steven, Director Bought 45,000 shares ($101K)
21 Jan 2026	Form 4: Simon Mark, Director Bought 11,061 shares ($25.3K)
21 Jan 2026	Form 4: Gerard Michael, General Counsel Bought 6,600 shares ($15K)
15 Oct 2025	Form 4: Gavel Steve, CHIEF COMMERCIAL OFFICER Granted 275,000 Stock Option (Right to Buy)

Comments